One Pager as on January 31, 2025
![]() | Flexibility to invest in opportunities across market capitalization |
![]() | Bottom up stock selection process |
![]() | Active allocation across Market capitalization based on macro-economic indicators, policy environment, valuations, market conditions |
![]() | Top down approach to select sectors |
![]() | Management through diversification of holdings and disciplined approach to monitor individual stock position based on market capitalization |
Sector | MMFCF* | Nifty 500 TRI |
Financial Services | 31.97% | 29.29% |
Information Technology | 8.36% | 10.46% |
Consumer Durables | 6.70% | 2.94% |
Fast Moving Consumer Goods | 6.22% | 7.00% |
Oil Gas & Consumable Fuels | 6.01% | 7.64% |
*Mahindra Manulife Flexi Cap Fund
Data as on January 31, 2025
Security | % to Net Assets |
HDFC Bank Limited | 9.05% |
ICICI Bank Limited | 8.27% |
Reliance Industries Limited | 4.55% |
Infosys Limited | 4.37% |
Larsen & Toubro Limited | 3.79% |
State Bank of India | 3.58% |
Tata Consultancy Services Limited | 2.98% |
Hindustan Unilever Limited | 2.93% |
Axis Bank Limited | 2.90% |
Bharti Airtel Limited | 2.68% |
Total | 45.10% |
Fresh Additions | Complete Exits |
Security | Security |
Bajaj Finance Limited | Dabur India Limited |
ITC Limited | Ola Electric Mobility Ltd |
TVS Motor Company Limited | Wipro Limited |
UltraTech Cement Limited | - |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio
changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager
may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult
their financial, tax and other advisors before taking any investment decision(s). Data as on January 31, 2025
Turnover Ratio (Last 1 year) | 0.84 |
Standard Deviation | 13.53% |
Beta | 0.93 |
Sharpe Ratio# | 0.55 |
Jenson's Alpha | 0.0078 |
#Risk-free rate assumed to be 6.65% (MIBOR as on 31-01-25) - Source:www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns for last
3 years. Data as on January 31, 2025.
^Benchmark ^^Additional Benchmark. Inception/Allotment date: 23-Aug-21.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. . *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 23-August-21.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha manage 11 schemes and Ms. Fatema Pacha manage 8 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on January 31, 2025
This product is suitable for investors who are seeking*:
• Long term capital appreciation.
• Investment in diversified portfolio of
equity & equity related instruments
across market capitalization
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.